Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LemnaTec is a German plant phenotyping and digital seed testing company that develops integrated hardware and software systems for image-based analysis of plants, seeds, seedlings, and related biological samples. Its commercial offerings span laboratory, greenhouse, and field applications, combining cameras, sensors, automation, image processing, and machine-learning-enabled analytics to measure plant growth, physiology, stress responses, disease-related phenotypes, and seed quality. The company serves agricultural and plant science customers including crop researchers, plant breeders, seed companies, agrochemical companies, and academic institutions. Founded in 1998 in Aachen, LemnaTec became part of the Nynomic group in 2019 and continues to operate under the LemnaTec name. The business is best characterized as an ag-biological research tools and phenomics platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LemnaTec.